Achieving a quantitative understanding of antiretroviral drug efficacy

Clinical Infectious Diseases

Volumn 51, Issue 9, 2010, Pages 1105-1106

  Shen, Lin ^a   Siliciano, Robert F ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DARUNAVIR; EFAVIRENZ; INDINAVIR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ANTIVIRAL ACTIVITY; DOSE RESPONSE; DRUG CONCENTRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; INSTANTANEOUS INHIBITORY POTENTIAL; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT DURATION;

ANTI-RETROVIRAL AGENTS; CLINICAL TRIALS AS TOPIC; DRUG MONITORING; HIV INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 77958542375     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/656688     Document Type: Letter

References (6)

1. Henrich TJ, Ribaudo HJ, Kuritzkes DR. Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy. Clin Infect Dis 2010; 51:93-98.
2. Shen L, Peterson S, Sedaghat AR, et al. Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs. Nat Med 2008; 14:762-766.
3. Hill AV. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol 1910; 40:iv-vii.
4. Holford NH, Sheiner LB. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981; 6:429-453.
5. Chou TC. Derivation and properties of Michaelis- Menten type and Hill type equations for reference ligands. J Theor Biol 1976; 59:253-276.
6. Hammer SM, Eron JJ Jr, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008; 300:555-570.